119 related articles for article (PubMed ID: 6362935)
21. Differences in dexamethasone-sensitivity between lymphocytes from patients with Alzheimer's disease and patients with multi-infarct dementia.
Nijhuis EW; Oostervink F; Hinloopen B; Rozing J; Nagelkerken L
Brain Behav Immun; 1996 Jun; 10(2):115-25. PubMed ID: 8811935
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion.
Klaus G; Mostert K; Reckzeh B; Mueller TF
Transplantation; 2003 Dec; 76(12):1719-24. PubMed ID: 14688522
[TBL] [Abstract][Full Text] [Related]
23. Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.
Sommerer C; Morath C; Giese T; Meuer S; Zeier M
Transplant Proc; 2008 Jun; 40(5):1416-8. PubMed ID: 18589120
[TBL] [Abstract][Full Text] [Related]
24. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
Braun DP; Harris JE
J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
[TBL] [Abstract][Full Text] [Related]
25. Cell number requirements for lymphocyte stimulation in vitro: changes during the course of multiple sclerosis and the effects of immunosuppression.
Knight SC; Harding B; Burman S; Mertin J
Clin Exp Immunol; 1981 Oct; 46(1):61-9. PubMed ID: 7039882
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K
Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes.
Bischof F; Melms A
Cell Immunol; 1998 Jul; 187(1):38-44. PubMed ID: 9682002
[TBL] [Abstract][Full Text] [Related]
28. Different reconstitution of peripheral blood lymphocytes and dendritic cells in liver and kidney transplant patients.
Rondelli D; Abbasian J; Arpinati M; Panaro F; Porubsky M; Manzelli A; Oberholzer J; Benedetti E; Testa G
Transplant Proc; 2005; 37(1):49-50. PubMed ID: 15808543
[TBL] [Abstract][Full Text] [Related]
29. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
Yaron I; Yaron R; Oluwole SF; Hardy MA
Cell Immunol; 1996 Mar; 168(2):258-66. PubMed ID: 8640873
[TBL] [Abstract][Full Text] [Related]
30. The effect of alpha 1 antitrypsin on the proliferative response of human peripheral blood lymphocytes.
Breit SN; Luckhurst E; Penny R
J Immunol; 1983 Feb; 130(2):681-6. PubMed ID: 6600250
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacy.
Hirano T; Oka K; Takeuchi H; Kozaki K; Matsuno N; Nagao T; Kozaki M; Ichikawa M; Yoshida M; Umezawa Y; Hirata M; Oh-i T; Koga M
Clin Pharmacol Ther; 1997 Dec; 62(6):652-64. PubMed ID: 9433394
[TBL] [Abstract][Full Text] [Related]
32. In vitro immunoresponsiveness in recipients of cadaveric renal allografts during ATG therapy.
Grosse-Wilde H; Jakubowski HD; Eigler FW; Kuwert EK
Proc Eur Dial Transplant Assoc; 1981; 18():481-5. PubMed ID: 7036170
[TBL] [Abstract][Full Text] [Related]
33. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
[TBL] [Abstract][Full Text] [Related]
34. S. aureus-induced B cell proliferation as a model for studying the effectiveness of immunosuppressive agents.
Górski A; Wasik M
Arch Immunol Ther Exp (Warsz); 1987; 35(5):651-5. PubMed ID: 3502685
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoids inhibit trypsin-induced DNA release from phytohemagglutinin-stimulated blood lymphocytes.
Distelhorst CW; Rogers JC
J Immunol; 1979 Jul; 123(1):487-95. PubMed ID: 448157
[TBL] [Abstract][Full Text] [Related]
36. [Modification of in vitro immune mechanisms by various glucocorticosteroid preparations--studies of lymphocytes in healthy probands and autoimmune patients].
Jahn S; Krohm P; Volk HD; Kiessig S; Grunow R; von Baehr R
Z Gesamte Inn Med; 1987 Mar; 42(6):160-3. PubMed ID: 3496720
[TBL] [Abstract][Full Text] [Related]
37. Effect of glucocorticoids on WBC counts in splenectomized renal transplant recipients.
Breitenfield RV; Pachucki LC; Hebert LA; Piering WF; Lemann J
Arch Intern Med; 1978 Apr; 138(4):583-5. PubMed ID: 345987
[TBL] [Abstract][Full Text] [Related]
38. Differential susceptibility in vitro to methylprednisolone of human lymphocyte subpopulations stimulated by phytohemagglutinin.
Kraft N; Atkins RC; Thomson NM
Transplant Proc; 1979 Jun; 11(2):1375-6. PubMed ID: 382521
[No Abstract] [Full Text] [Related]
39. Glucocorticoid levels and lymphocyte functions in kidney transplanted patients.
Langhoff E; Hvidberg EF; Flachs H; Ladefoged J
Pharmacol Toxicol; 1987 Apr; 60(4):269-73. PubMed ID: 3295838
[TBL] [Abstract][Full Text] [Related]
40. The comparison of antibody-dependent (ADCC) and lectin-induced (LICC) cytotoxic activities of human blood lymphocytes in healthy and diseased subjects.
Wasik M; Gradowska L; Klepacka J; Rancewicz Z; Orłowski T
Arch Immunol Ther Exp (Warsz); 1983; 31(1):15-22. PubMed ID: 6351796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
